Vein and circulation
An IV route introduces material into the vascular system.
The clinical question: What exact product and systemic exposure evidence apply?
The Paragon AtlasPatient field guide / 17Approx. 9 min read
Patient safety guide
Route and technology
do not prove benefit.
A patient safety resource about IV or nebulized cell and exosome products and EBOO. These are not offered here as established treatments.
Explore available careInformation only · not a treatment offerUpdated October 15, 2026
01Muscles + tendons02Joints + ligaments03Spine + extremities
A useful place to begin
More understanding.
A better next question.
How a product enters the body matters. An IV introduces it into the circulation, while a nebulizer creates an aerosol that is inhaled. An extracorporeal procedure handles blood outside the body before returning it. Each raises different safety questions. Understanding the route is a first step, but it does not tell you whether the product or procedure helps a condition.
- Exosomes
- Commercial products vary widely
- IV + nebulized routes
- Separate safety questions
- EBOO
- Not currently offered
IV + nebulized products
A delivery route cannot validate the product.
Administration by IV push, infusion or nebulizer introduces route specific safety questions. It does not establish product identity, sterility, dose consistency or evidence for a disease.
Paragon Regen Centers does not represent cell or exosome products delivered by these routes as established treatments for orthopedic, neurologic, behavioral health or wellness conditions.
Neurologic + behavioral health
Use qualified, established care.
Traumatic brain injury, PTSD, anxiety and other neurologic or behavioral health symptoms require evaluation by appropriately qualified clinicians. No exosome product is established to treat these conditions.
Call 911 for loss of consciousness, seizure, stroke like symptoms, severe confusion, suicidal thoughts or another emergency.
EBOO
The exact process and evidence matter.
Extracorporeal blood oxygenation and ozonation, commonly called EBOO, refers to procedures in which blood is removed, exposed to ozone and sometimes ultraviolet light, and returned intravenously.
Paragon Regen Centers does not currently offer EBOO. Anyone considering a similar procedure elsewhere should ask for the exact device, full protocol, condition specific human evidence, infection controls and a plan for complications related to blood removal and reinfusion.
Questions to ask
Insist on exact, verifiable answers.
- What is the exact product or device?
- What does the full protocol involve?
- What human evidence applies to the exact protocol?
- What route specific complications are possible?
- What established alternatives exist?
- Who manages complications and long term follow up?
The anatomy
Different routes expose different anatomy.
Respiratory tract
A nebulized aerosol reaches the airways through inhalation.
The clinical question: What inhalation specific safety and clinical evidence support the claim?
External blood circuit
An extracorporeal process handles blood outside the body before return.
The clinical question: What device, intended use, human evidence and risk controls apply?
Proposed treatment target
The structure a claim promises to help is distinct from the place a product enters the body.
The clinical question: What evidence connects delivery to a meaningful outcome at that target?
A closer look
Trace the proposed exposure through the body.
The route and equipment are part of the intervention. Understanding them helps distinguish an exposure claim from a demonstrated therapeutic effect.
Entry into the body is not the same as reaching a target.
A proposal may describe how material enters a vein or is inhaled and then imply that it acts at an injured structure. Those are separate claims. Distribution, persistence and biological effect require evidence for the actual preparation and route.
Ask where the material is expected to go and what supports that expectation. Then ask whether a meaningful human outcome was demonstrated. A route diagram may explain an idea, but it cannot establish that symptoms improve or that the same approach is appropriate across joints, the nervous system and unrelated conditions.
Inhaled and IV preparations require different assessment.
The respiratory tract and vascular system create different exposures. A study of local injection does not settle the questions of inhalation or IV use. The formulation, administration method and intended condition should be assessed together.
Ask what route specific human evidence exists and whether the material used in the study matches the proposed product. Also clarify how complications would be recognized and managed. The fact that a nebulizer or IV device is familiar in conventional medicine does not validate every material placed into it or every claim made for that combination.
An extracorporeal circuit adds equipment questions.
A procedure that removes blood into an external circuit and returns it involves more than a product label. The exact devices, intended use, protocol, handling and risk controls need identification. A sophisticated appearance cannot establish that the proposed procedure has a supported benefit.
Ask how every device is used in the actual protocol and what clinical outcome is being claimed. For EBOO, Paragon does not currently offer the service. A review should examine the precise proposal and matching human evidence rather than rely on general language about oxygenation, cleansing or optimization.
Neurologic and behavioral symptoms need their own care pathway.
Symptoms following a head injury, PTSD, anxiety and other concerns should not be collapsed into a broad inflammation story. They require qualified assessment and an appropriate plan for the actual diagnosis. Interest in an emerging intervention should not interrupt that work.
Ask which clinician is responsible for evaluating the symptom pattern and coordinating established care. If symptoms change in a way that requires urgent evaluation, product review is not the immediate task. A useful educational consultation keeps the clinical need in view rather than allowing an unfamiliar technology to become the center of every decision.
Equipment familiarity can create an evidence shortcut.
People may recognize an IV line, a nebulizer or a blood handling circuit from other medical settings. That familiarity can make an unfamiliar protocol seem more established than it is. The equipment’s ordinary use does not validate a new material, a different intended purpose or a claim about a distant anatomical target.
Ask what part of the proposed intervention is established and what part remains uncertain or unsupported. The answer should identify the complete combination rather than borrow credibility from a familiar component. If a clinician cites device documentation, ask whether it describes the actual intended use. If a product study is cited, ask whether the same route was used. A useful review makes the boundaries of each piece of evidence explicit and keeps appropriate care for the underlying condition at the center.
A conversation example
Does a gentler sounding route change the evidence?
An example of a care conversation
“A nebulizer seems less invasive. Does that make exosomes a reasonable option after a brain injury?”
What your clinician can explain
A familiar or comfortable sounding delivery method does not tell you whether the product helps. Ask what the preparation is, what inhalation research applies and whether human evidence supports the brain injury claim. Product identity, route specific risk and uncertainty need explaining too. A diagram of possible delivery is not evidence of benefit. Alongside that review, ask which qualified clinician should assess the symptoms and coordinate appropriate care. This resource does not offer nebulized exosome treatment.
What the explanation should be clear about
A route that sounds less invasive is not automatically safer or effective. Familiar equipment cannot establish the suitability of an unfamiliar material, and delivery theory cannot substitute for a clinical outcome.
What you can ask next
Bring the complete product and protocol information to a qualified clinician while continuing indicated care. Ask which claim is demonstrated, which is hypothetical and what symptoms need prompt medical assessment rather than further product research.
Questions worth asking
Questions worth talking through.
What is administered, and where does it go?
Ask for the exact material, route and intended target. A phrase such as “systemic healing” is too broad. The proposal should explain the exposure being created and the specific condition and outcome it is supposed to address.
What evidence applies to this route?
A study using a local injection cannot settle the questions of IV or inhaled administration. Product, preparation, dose, route and patient population all affect relevance. Ask which human evidence supports the complete proposed protocol.
If equipment is involved, what device and purpose apply?
A sophisticated circuit or nebulizer does not show that the material helps the intended condition. For an extracorporeal procedure, identify every relevant device, its role and the complete protocol.
Could this delay appropriate neurologic or behavioral health care?
Symptoms after a brain injury, PTSD or anxiety deserve qualified assessment. The desire for a new option should not postpone a suitable diagnosis, established treatment or urgent evaluation when symptoms change.
In real life
How this can come up in everyday life.
These are illustrative situations, not patient stories or personal recommendations. The details of an individual evaluation can lead to a different plan.
Inhalation described as direct delivery to the brain
An illustrative claim uses an anatomical diagram to imply a nebulized product treats neurologic symptoms.
What to discuss
An appealing pathway diagram does not demonstrate distribution, safety or clinical benefit from a specific preparation in people. The product and route need their own human evidence.
A useful next step
Ask for the exact human study and seek an appropriate clinician for the neurologic concern.
IV administration described as universal access
A proposal suggests that entering the bloodstream proves a material reaches the desired target and helps it.
What to discuss
Exposure and therapeutic effect are separate questions. The vascular route does not establish where a preparation acts, what harms may occur or whether an outcome is improved.
A useful next step
Request evidence for the exact route, product identity and intended use.
An EBOO device promoted through “detox” language
A procedure involving an external blood circuit is described without a defined diagnosis or measurable endpoint.
What to discuss
The device, protocol, intended use and evidence need precise definition. General cleansing language does not supply a clinically assessable benefit. Paragon does not currently offer EBOO.
A useful next step
Ask for the exact device, complete protocol and matching human evidence, then compare appropriate care for the underlying concern.
Visit field notes
What to expect before and after your visit.
Before the visit
- Collect the full protocol, exact product or device and administration route.
- Write down the actual diagnosis and symptom the proposal is intended to treat.
- Bring current specialist care information so a review does not fragment the existing plan.
In the conversation
- Separate claims about delivery from claims about clinical effect.
- Ask what evidence addresses the whole protocol rather than one component.
- Confirm appropriate established or urgent care for the symptom pattern.
Before you leave
- Continue indicated care and do not replace it with an unverified route based claim.
- Keep product, device and procedure records if a treatment has already occurred.
- Seek prompt medical assessment for concerning symptoms and ask about relevant adverse event reporting.
Plain language
Medical terms in everyday language.
- Intravenous
- Administered into a vein.
- Nebulization
- Converting a liquid into an aerosol for inhalation.
- Extracorporeal
- Occurring outside the body, such as in an external blood circuit.
- Systemic exposure
- Exposure involving the circulation or body more broadly rather than one local site.
Take this with you
A few things to remember.
Your conversation checklist
- A route is an exposure description, not proof of effectiveness.
- Product and device questions must be assessed separately and together.
- IV or nebulized biologic treatment and EBOO are not offered through this resource.
What to keep in mind
A few details worth keeping in mind.
- 01
Separate
Evaluate the product or device and the delivery route as two different safety questions.
- 02
Escalate
Use emergency or qualified specialty care for serious neurologic, behavioral health or rapidly worsening symptoms.
- 03
Document
Keep the identity, claims, consent, evidence and complication plan before any decision.
Questions worth saving
- What exact product or device is being used?
- What human evidence supports this exact use and route?
- What route specific complications are possible and who can manage them?
- Which established medical or behavioral health alternatives apply?
Direct answers
A little more clarity.
No. A route does not establish product quality, safety or effectiveness.
No. Current human evidence does not establish these products as routine care for those uses.
No. It is not currently offered.
Patients encounter these claims elsewhere. This page provides safety context and practical questions without inviting treatment.
Sources + editorial note
Go to the source.
Use primary sources to check a claim in its full context. This page is educational. Personal recommendations depend on your history, examination, goals and the judgment of an appropriately qualified clinician.
Published by Paragon Regen Centers. Updated October 15, 2026. Use this page to prepare for a conversation with your clinician. Your medical history, examination and personal goals guide individual care.
Information, not an offer
Put urgent symptoms first.
For urgent symptoms, seek appropriate emergency or specialty care rather than delaying care for an emerging product or procedure.
Read safety guidance